BFA
IHE icon

Brendel Financial Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Brendel Financial Advisors’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
+11,958
New +$1.08M 0.55% 46

Other funds holding IHE

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
FP
FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Arkansas Financial Group Little Rock, Arkansas $768M AUM 16.55% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Brendel Financial Advisors's IHE Position: Q2 2026 in Review

Brendel Financial Advisors opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q2 2026: 11,958 shares worth $1.18M. The stake represents 0.55% of the portfolio and ranks #46 among its holdings.

83 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Brendel Financial Advisors held 11,958 shares of iShares US Pharmaceuticals ETF worth $1.18M as of Q2 2026.
  • iShares US Pharmaceuticals ETF was a new Brendel Financial Advisors position in Q2 2026.
  • iShares US Pharmaceuticals ETF made up 0.55% of Brendel Financial Advisors's portfolio in Q2 2026, its #46 holding.
  • 83 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Brendel Financial Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.